Viridian Therapeutics, Inc./DE Revenue, Net (Deprecated 2018-01-31)
Viridian Therapeutics, Inc./DE (VRDN) reported Revenue, Net (Deprecated 2018-01-31) of $4.78 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-09
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $4.78M, a 935.50% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.19M, a 134.18% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.63M, a 74.25% increase year-over-year.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $718.00K, a 35.61% decline year-over-year.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for fiscal 2017 was $4.00M, a 15.13% increase from fiscal 2016.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for fiscal 2016 was $3.48M, a 37.00% increase from fiscal 2015.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for fiscal 2015 was $2.54M, a 41.25% decline from fiscal 2014.
- Viridian Therapeutics, Inc./DE revenue, net (deprecated 2018-01-31) for fiscal 2014 was $4.32M, a 0.09% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $4.78M 10-Q · filed 2018-05-09 | $5.98M derived: sum of 2 quarters · filed 2018-05-09 | $7.61M derived: sum of 3 quarters · filed 2018-05-09 | $8.32M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $1.19M 10-K · filed 2018-03-15 | $2.82M derived: sum of 2 quarters · filed 2018-03-15 | $3.54M derived: sum of 3 quarters · filed 2018-03-15 | $4.00M 10-K · filed 2018-03-15 | ||||
| 2017-09-30 | $1.63M 10-K · filed 2018-03-15 | $2.35M derived: sum of 2 quarters · filed 2018-03-15 | $2.81M 10-Q · filed 2017-11-09 | $3.32M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $718.00K 10-K · filed 2018-03-15 | $1.18M 10-Q · filed 2017-08-11 | $1.69M derived: sum of 3 quarters · filed 2018-05-09 | $2.63M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | $462.00K 10-Q · filed 2018-05-09 | $971.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.91M derived: sum of 3 quarters · filed 2018-05-09 | $3.02M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $509.00K 10-K · filed 2018-03-15 | $1.45M derived: sum of 2 quarters · filed 2018-03-15 | $2.56M derived: sum of 3 quarters · filed 2018-03-15 | $3.48M 10-K · filed 2018-03-15 | $3.34M 10-K · filed 2017-03-24 | |||
| 2016-09-30 | $936.00K 10-K · filed 2018-03-15 | $889.00K 10-Q · filed 2016-10-26 | $2.05M derived: sum of 2 quarters · filed 2018-03-15 | $2.97M 10-Q · filed 2017-11-09 | $2.58M 10-Q · filed 2016-10-26 | $3.63M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-06-30 | $1.11M 10-K · filed 2018-03-15 | $874.00K 10-Q · filed 2016-08-15 | $2.03M 10-Q · filed 2017-08-11 | $1.69M 10-Q · filed 2016-08-15 | $2.69M derived: sum of 3 quarters · filed 2018-03-15 | $3.19M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-03-31 | $917.00K 10-K · filed 2018-03-15 | $818.00K 10-Q · filed 2016-05-16 | $1.58M derived: sum of 2 quarters · filed 2018-03-15 | $2.08M derived: sum of 3 quarters · filed 2018-03-15 | $2.81M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $1.16M derived: sum of 2 quarters · filed 2017-03-24 | $1.89M derived: sum of 3 quarters · filed 2017-03-24 | $2.54M 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | $501.00K 10-Q · filed 2016-10-26 | $1.24M derived: sum of 2 quarters · filed 2016-10-26 | $1.88M 10-Q · filed 2016-10-26 | $2.54M derived: sum of 4 quarters · filed 2016-10-26 | ||||
| 2015-06-30 | $734.00K 10-Q · filed 2016-08-15 | $1.38M 10-Q · filed 2016-08-15 | $2.03M derived: sum of 3 quarters · filed 2016-08-15 | $3.33M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $645.00K 10-Q · filed 2016-05-16 | $1.30M derived: sum of 2 quarters · filed 2016-05-16 | $2.60M derived: sum of 3 quarters · filed 2016-05-16 | $3.88M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $1.96M derived: sum of 2 quarters · filed 2016-03-21 | $3.23M derived: sum of 3 quarters · filed 2016-03-21 | $4.32M 10-K · filed 2016-03-21 | ||||
| 2014-09-30 | $1.30M 10-Q · filed 2015-11-13 | $1.30M 10-Q · filed 2014-11-14 | $2.58M derived: sum of 2 quarters · filed 2015-11-13 | $3.67M 10-Q · filed 2015-11-13 | $3.67M 10-Q · filed 2014-11-14 | $4.76M derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $1.27M 10-Q · filed 2015-08-14 | $1.27M 10-Q · filed 2014-08-14 | $2.36M 10-Q · filed 2015-08-14 | $2.36M 10-Q · filed 2014-08-14 | $3.46M derived: sum of 3 quarters · filed 2015-08-14 | $4.44M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $1.09M 10-Q · filed 2015-05-15 | $2.18M derived: sum of 2 quarters · filed 2015-05-15 | $3.16M derived: sum of 3 quarters · filed 2015-05-15 | $4.27M derived: sum of 4 quarters · filed 2015-05-15 | ||||
| 2013-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $2.07M derived: sum of 2 quarters · filed 2015-03-27 | $3.18M derived: sum of 3 quarters · filed 2015-03-27 | $4.32M 10-K · filed 2015-03-27 | ||||
| 2013-09-30 | $983.59K 10-Q · filed 2014-11-14 | $2.09M derived: sum of 2 quarters · filed 2014-11-14 | $3.23M 10-Q · filed 2014-11-14 | |||||
| 2013-06-30 | $1.10M 10-Q · filed 2014-08-14 | $2.24M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |